Posts tagged as:

Pharmaceutical fraud

Schwarz Pharma Pays U.S. $22 Million to Settle False Claims Allegations in health care fraud qui tam case brought by Nolan & Auerbach, P.A. client

by Nolan and Auerbach on April 30, 2010

Schwarz Pharma, Inc. agreed to pay the United States $22 million to resolve False Claims Act allegations relating to the sale of two drugs that had never been FDA-approved as required by law. The United States Department of Justice (DOJ) announced the settlement in an April 20, 2010 press release.

For more information about qui tam law and health care fraud, contact Nolan & Auerbach, P.A.

{ 0 comments }

Medicis Pharmaceutical Pays $9.8 Million to Settle False Claims Accusations

by Nolan and Auerbach on May 17, 2007

Medicis Pharmaceutical, located in Scottsdale, Arizona, is paying $9.8 million to settle False Claims Act allegations.  This case was brought by four former Medicis sales representatives. The allegations centered around Loprox, a topical skin preparation.  Loprox, while approved by the FDA as a fungicide for patients over 10 years of age, was off-label marketed for the treatment of diaper rash.  This marketing or promoting for unapproved uses by Medicis Pharmaceutical is prohibited.

To read more about this case, click here or  to read more on filing qui tam actions go to Nolan & Auerbach.

{ 0 comments }